Healthcare · Active clinical trials
In 2026, Germany reported 1.2 K units active clinical trials, ranking 8 out of 197. This zero figure does not mean a lack of research; rather, many trials are conducted at university hospitals and are not captured in international registries. German pharmaceuticals, among Europe's strongest, focus on preclinical development and biotechnology, areas where the country has long excelled.
Data for 2026 · unit: units
Position
#8 / 197
Germany world ranking
Country position on the scale from last to first place for this indicator.
DE
#8
#197#1
Trend
Change over time
Change in indicator over the available period.
500
1990
1.2 K
2000
2.5 K
2010
3 K
2020
1.2 K
2025
1.2 K
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Germany stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Germany — how much?
Based on 2026 data — 1.2 K units. This is rank #8 out of 197 countries.
What is Germany's rank by Active clinical trials?
Germany ranks #8 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Germany?
Over the available period the indicator changed from 500 to 1.2 K units.